KEY FINDINGS
The global non-alcoholic steatohepatitis (NASH) biomarker market is projected to grow with a CAGR of 20.65%, over the forecast period of 2021 to 2028. The market growth is mainly accredited to factors, such as, the rising NASH affected population, the surging awareness associated with non-alcoholic fatty liver disease, the increasing occurrence of chronic diseases, and the increasing prevalence of obesity and diabetes.
MARKET INSIGHTS
Non-alcoholic steatohepatitis (NASH), a highly destructive form of non-alcoholic fatty liver disease (NAFLD), often develops into more severe disorders, like hepatocellular carcinoma and cirrhosis. As a result, NASH is projected to surpass the hepatitis C virus infection and become the leading cause of liver transplantation, worldwide, over the upcoming decade. As these diseases progress, the liver experiences fibrosis and scarring, ultimately leading to cirrhosis. Liver fibrosis is likely to result in permanent organ damage, progress to hepatocellular carcinoma, and liver failure.
Obesity is a well-recognized epidemic, globally. The increasing incidence and prevalence of obesity have surged drastically, over the last ten years. For instance, according to the World Health Organization (WHO) 2020 report, more than 1.9 billion adults, aged 18 and older, were overweight in 2016. Out of which, 650 million individuals were obese. In addition, 38 million children below the age of 5 were overweight or obese in 2019. On the other hand, as per the 2020 Diabetes Research and Clinical Practice report, the worldwide prevalence of diabetes in 2019, was nearly 9.3%, and is expected to rise to 10.2% by 2030.
REGIONAL INSIGHTS
The global non-alcoholic steatohepatitis (NASH) biomarker market growth is evaluated by assessing the Asia Pacific, North America, Europe, and the rest of the world. The Asia Pacific is set to be the fastest-growing market over the forecast period. The region's market growth is attributed to the enhanced healthcare infrastructure, improved economic conditions, and rising healthcare awareness in developing countries like China and India.
COMPETITIVE INSIGHTS
The industrial rivalry is anticipated to be moderate, owing to the unavailability of treatment. Besides, key market players focus on research, development, and partnerships, in order to introduce products into the market. Some of the leading companies operating in the market are, Merck & Co, AstraZeneca, Novartis AG, Pfizer Inc, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market Forecast 2021-2028
Table Of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Growing Nash Affected Population
3.1.2. Surging Prevalence Of Obesity And Diabetes
3.1.3. Increasing Occurrence Of Chronic Diseases
3.1.4. Surging Awareness Of Non-Alcoholic Fatty Liver Disease
3.2. Key Restraints
3.2.1. Side-Effects And Risks Associated With Nash Therapeutics
3.2.2. Lack Of Specialized Diagnostic Test For Non-Alcoholic Fatty Liver Disease (Nafld)
4. Key Analytics
4.1. Porter's Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Non-Alcoholic Steatohepatitis (Nash) Biomarker Market
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights
5. Market By Type
5.1. Serum Biomarker
5.2. Hepatic Fibrosis Biomarker
5.3. Apoptosis Biomarker
5.4. Oxidative Stress Biomarker
5.5. Other Types
6. Market By End-User
6.1. Pharma & Cro Industry
6.2. Diagnostic Lab
6.3. Academic Research Key
6.4. Hospital
7. Geographical Analysis
7.1. North America
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. The United States
7.1.5.2. Canada
7.2. Europe
7.2.1. Market Size & Estimates
7.2.2. Key Growth Enablers
7.2.3. Key Challenges
7.2.4. Key Players
7.2.5. Country Analysis
7.2.5.1. Germany
7.2.5.2. France
7.2.5.3. The United Kingdom
7.2.5.4. Italy
7.2.5.5. Russia
7.2.5.6. Belgium
7.2.5.7. Poland
7.2.5.8. Rest Of Europe
7.3. Asia Pacific
7.3.1. Market Size & Estimates
7.3.2. Key Growth Enablers
7.3.3. Key Challenges
7.3.4. Key Players
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.2. Japan
7.3.5.3. Australia & New Zealand
7.3.5.4. India
7.3.5.5. South Korea
7.3.5.6. Thailand
7.3.5.7. Indonesia
7.3.5.8. Vietnam
7.3.5.9. Rest Of Asia Pacific
7.4. Rest Of World
7.4.1. Market Size & Estimates
7.4.2. Key Growth Enablers
7.4.3. Key Challenge
7.4.4. Key Players
7.4.5. Regional Analysis
7.4.5.1. Latin America
7.4.5.2. Middle East & Africa
8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Merger & Acquisitions
8.1.2. Product Launch & Developments
8.1.3. Partnership, Contract/Agreement & Collaboration
8.1.4. Business Expansion/ Approval/ Announcement
8.2. Company Profile
8.2.1. Allergan Plc (Acquired By Abbvie)
8.2.2. Astrazeneca
8.2.3. Bristol -Myers Squibb Company
8.2.4. Genfit Sa
8.2.5. Gilead Sciences, Inc
8.2.6. Madrigal Pharmaceuticals
8.2.7. Merck & Co
8.2.8. Novartis Ag
8.2.9. Novo Nordisk
8.2.10. Pfizer Inc
8.2.11. Siemens Healthineers
8.2.12. Viking Therapeutics
8.2.13. Zydus Cadila
List Of Tables
Table 1: Market Snapshot - Non-Alcoholic Steatohepatitis (Nash) Biomarker
Table 2: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 3: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 4: Global Serum Biomarker Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 5: Global Serum Biomarker Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 6: Global Hepatic Fibrosis Biomarker Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 7: Global Hepatic Fibrosis Biomarker Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 8: Global Apoptosis Biomarker Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 9: Global Apoptosis Biomarker Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 10: Global Oxidative Stress Biomarker Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 11: Global Oxidative Stress Biomarker Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 12: Global Other Types Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 13: Global Other Types Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 14: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By End-User, Historical Years, 2016-2020 (In $ Million)
Table 15: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By End-User, Forecast Years, 2021-2028 (In $ Million)
Table 16: Global Pharma & Cro Industry Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 17: Global Pharma & Cro Industry Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 18: Global Diagnostic Lab Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 19: Global Diagnostic Lab Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 20: Global Academic Research Key Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 21: Global Academic Research Key Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 22: Global Hospital Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 23: Global Hospital Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 24: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 25: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 26: North America Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 27: North America Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Country, Forecast Years, 2021-2028 (In $ Million)
Table 28: Leading Players Operating In North America Non-Alcoholic Steatohepatitis (Nash) Biomarker Market
Table 29: Europe Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 30: Europe Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Country, Forecast Years, 2021-2028 (In $ Million)
Table 31: Leading Players Operating In Europe Non-Alcoholic Steatohepatitis (Nash) Biomarker Market
Table 32: Asia Pacific Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 33: Asia Pacific Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Country, Forecast Years, 2021-2028 (In $ Million)
Table 34: Leading Players Operating In Asia Pacific Non-Alcoholic Steatohepatitis (Nash) Biomarker Market
Table 35: Rest Of World Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Region, Historical Years, 2016-2020 (In $ Million)
Table 36: Rest Of World Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Region, Forecast Years, 2021-2028 (In $ Million)
Table 37: Leading Players Operating In Rest Of World Non-Alcoholic Steatohepatitis (Nash) Biomarker Market
List Of Figures
Figure 1: Porter's Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Type, In 2020
Figure 6: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Serum Biomarker, 2021-2028 (In $ Million)
Figure 7: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Hepatic Fibrosis Biomarker, 2021-2028 (In $ Million)
Figure 8: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Apoptosis Biomarker, 2021-2028 (In $ Million)
Figure 9: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Oxidative Stress Biomarker, 2021-2028 (In $ Million)
Figure 10: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Other Types, 2021-2028 (In $ Million)
Figure 11: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By End-User, In 2020
Figure 12: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Pharma & Cro Industry, 2021-2028 (In $ Million)
Figure 13: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Diagnostic Lab, 2021-2028 (In $ Million)
Figure 14: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Academic Research Key, 2021-2028 (In $ Million)
Figure 15: Global Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, By Hospital, 2021-2028 (In $ Million)
Figure 16: North America Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, Country Outlook, 2020 & 2028 (In %)
Figure 17: United States Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 18: Canada Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 19: Europe Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, Country Outlook, 2020 & 2028 (In %)
Figure 20: Germany Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 21: France Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 22: United Kingdom Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 23: Italy Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 24: Russia Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 25: Belgium Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 26: Poland Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 27: Rest Of Europe Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 28: Asia Pacific Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, Country Outlook, 2020 & 2028 (In %)
Figure 29: China Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 30: Japan Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 31: Australia & New Zealand Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 32: India Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 33: South Korea Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 34: Thailand Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 35: Indonesia Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 36: Vietnam Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 37: Rest Of Asia Pacific Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 38: Rest Of World Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, Regional Outlook, 2020 & 2028 (In %)
Figure 39: Latin America Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Figure 40: Middle East & Africa Non-Alcoholic Steatohepatitis (Nash) Biomarker Market, 2021-2028 (In $ Million)
Global Clinical Trial Support Services Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 107
Market Overview of Global Clinical Trial Support Services market:
According to our latest research, the global Clinical Trial Support Services market looks promising in the next 5 years. As of 2022, the global Clinical Trial Support Services market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Clinical trial support services are the various services, which pharmaceutical companies use durin......
Global Clinical Trial Supplies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Clinical Trial Supplies market:
According to our latest research, the global Clinical Trial Supplies market looks promising in the next 5 years. As of 2022, the global Clinical Trial Supplies market was estimated at USD 1939.69 million, and it's anticipated to reach USD 3477.51 million in 2028, with a CAGR of 10.22% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
Global Clinical Trial Management System (CTMS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 09-Nov-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Clinical Trial Management System (CTMS) market:
According to our latest research, the global Clinical Trial Management System (CTMS) market looks promising in the next 5 years. As of 2022, the global Clinical Trial Management System (CTMS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a ......
Global Bladder Cancer Clinical Trials Market Status and Outlook 2023-2028
Published: 07-Nov-2023 Price: US 3160 Onwards Pages: 107
A clinical trial is a research study that tries to find better ways to prevent, screen for, diagnose, or treat a disease. Clinical trials are an essential part of cancer research. They may provide possible treatment alternatives to patients who have not had success with standard and approved therapies.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Global Forecast to 2028
Published: 09-Oct-2023 Price: US 4950 Onwards Pages: 340
“The clinical trial supplies market is projected to grow at a CAGR of 9.9% during the forecast period of 2023-2028.”
The global clinical trial supplies market size is projected to reach USD 6.3 billion by 2028 from USD 3.9 billion in 2023, at a CAGR of 9.9% during the forecast period. Factors such as Increasing number of clinical trials, Growing product pipeline, and Increasing decentralization of clinical trials are likely to have positive impact on the m......
Global Clinical Trials Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Oct-2023 Price: US 3380 Onwards Pages: 109
Market Overview of Global Clinical Trials market:
According to our latest research, the global Clinical Trials market looks promising in the next 5 years. As of 2022, the global Clinical Trials market was estimated at USD 29710.78 million, and it's anticipated to reach USD 50447.34 million in 2028, with a CAGR of 9.22% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Clinical Tri......
Global Hypoparathyroidism Clinical Trials Market Insights, Forecast to 2029
Published: 20-Sep-2023 Price: US 4900 Onwards Pages: 74
Market Analysis and Insights: Global Hypoparathyroidism Clinical Trials Market
The global Hypoparathyroidism Clinical Trials market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Hypoparathyroidism Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Th......
Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028
Published: 08-Sep-2023 Price: US 4950 Onwards Pages: 353
“Increasing number of drugs in pipeline and rise in number of clinical trials are driving the growth of the clinical trials market.”
The global clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing demand for specialized testing services. Companies are increasingly outsourcing specialize......
Global Clinical Trials Market Insights, Forecast to 2029
Published: 08-Aug-2023 Price: US 4900 Onwards Pages: 111
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
